Is ‘GOLD’ standard for the management of COPD in clinical practice?
Summary: primary therapy for chronic obstructive pulmonary disease (COPD) is the removal of the toxic agent (in most cases, tobacco smoke). Additional therapy includes bronchodilators. Inhaled corticosteroids and long-acting bronchodilators can be used to prevent and reduce the risk of exacerbations...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BioExcel Publishing Ltd
2012-11-01
|
| Series: | Drugs in Context |
| Subjects: | |
| Online Access: | http://drugsincontext.com/individual/is-gold-standard-for-the-management-of-copd-in-clinical-practice |
| _version_ | 1828422828526927872 |
|---|---|
| author | Barbara Yawn |
| author_facet | Barbara Yawn |
| author_sort | Barbara Yawn |
| collection | DOAJ |
| description | Summary: primary therapy for chronic obstructive pulmonary disease (COPD) is the removal of the toxic agent (in most cases, tobacco smoke). Additional therapy includes bronchodilators. Inhaled corticosteroids and long-acting bronchodilators can be used to prevent and reduce the risk of exacerbations. COPD is a systemic disease and often requires therapy of its protean-associated morbidities from depression to osteoporosis and muscle wasting. Despite pessimism from some, COPD is treatable. |
| first_indexed | 2024-12-10T15:52:19Z |
| format | Article |
| id | doaj.art-47e00878c50846a496c1e145430d3776 |
| institution | Directory Open Access Journal |
| issn | 1740-4398 |
| language | English |
| last_indexed | 2024-12-10T15:52:19Z |
| publishDate | 2012-11-01 |
| publisher | BioExcel Publishing Ltd |
| record_format | Article |
| series | Drugs in Context |
| spelling | doaj.art-47e00878c50846a496c1e145430d37762022-12-22T01:42:45ZengBioExcel Publishing LtdDrugs in Context1740-43982012-11-0111410.7573/dic.212243Is ‘GOLD’ standard for the management of COPD in clinical practice?Barbara YawnSummary: primary therapy for chronic obstructive pulmonary disease (COPD) is the removal of the toxic agent (in most cases, tobacco smoke). Additional therapy includes bronchodilators. Inhaled corticosteroids and long-acting bronchodilators can be used to prevent and reduce the risk of exacerbations. COPD is a systemic disease and often requires therapy of its protean-associated morbidities from depression to osteoporosis and muscle wasting. Despite pessimism from some, COPD is treatable.http://drugsincontext.com/individual/is-gold-standard-for-the-management-of-copd-in-clinical-practicechronic bronchitisCOPDemphysemaexacerbationsFEV1formoterolFVCGOLDimmunizationindacaterolLABALAMALTRAmethylxanthinesrespimatroflumilastSGRQtiotropiumTORCHUPLIFT |
| spellingShingle | Barbara Yawn Is ‘GOLD’ standard for the management of COPD in clinical practice? Drugs in Context chronic bronchitis COPD emphysema exacerbations FEV1 formoterol FVC GOLD immunization indacaterol LABA LAMA LTRA methylxanthines respimat roflumilast SGRQ tiotropium TORCH UPLIFT |
| title | Is ‘GOLD’ standard for the management of COPD in clinical practice? |
| title_full | Is ‘GOLD’ standard for the management of COPD in clinical practice? |
| title_fullStr | Is ‘GOLD’ standard for the management of COPD in clinical practice? |
| title_full_unstemmed | Is ‘GOLD’ standard for the management of COPD in clinical practice? |
| title_short | Is ‘GOLD’ standard for the management of COPD in clinical practice? |
| title_sort | is gold standard for the management of copd in clinical practice |
| topic | chronic bronchitis COPD emphysema exacerbations FEV1 formoterol FVC GOLD immunization indacaterol LABA LAMA LTRA methylxanthines respimat roflumilast SGRQ tiotropium TORCH UPLIFT |
| url | http://drugsincontext.com/individual/is-gold-standard-for-the-management-of-copd-in-clinical-practice |
| work_keys_str_mv | AT barbarayawn isgoldstandardforthemanagementofcopdinclinicalpractice |